Furthermore, patients treated with first-line platinum/paclitaxel for ovarian cancer had a poor overall and disease-free survival in tumors exhibiting methylated ASS1 compared with unmethylated ASS1 [50,52]. The gene discussed is ASS1; the disease is ovarian cancer.